Advanced Lung Small Cell Carcinoma: Clinical Trials

2 trials for Advanced Lung Small Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2

Follow Advanced Lung Small Cell Carcinoma: new trials by email Literature Review of Advanced Lung Small Cell Carcinoma trials Research Report on Advanced Lung Small Cell Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)82021-11-222026-05-28
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Cisplatin, Elimusertib, Gemcitabine Hydrochloride - Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)742021-08-252026-07-31

Narrower conditions

Lung Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Triple Negative Breast Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Medullary (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  HIV Infections (1)  ·  Melanoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasm Metastasis (1)  ·  Penile Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Sarcoma, Kaposi (1)

Broader conditions

Adnexal Diseases (2)  ·  Breast Diseases (2)  ·  Breast Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Female (2)  ·  Genital Neoplasms, Male (2)  ·  Gonadal Disorders (2)  ·  Lung Diseases (2)  ·  Male Urogenital Diseases (2)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  BAY 1895344 (1)  ·  Cisplatin (1)  ·  Gemcitabine (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nivolumab (1)  ·  Platinum (1)  ·  Specimen Handling (1)  ·  cabozantinib (1)

Sponsors

National Cancer Institute (NCI) (2)

Countries

United States (2)  ·  Canada (1)

Top investigators

Haiying Cheng (1)  ·  Mamta Parikh (1)

Results publications

PMID 42847673

NIH funding

UM1CA186717 (1)